Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06939517 · ClinicalTrials.gov registry record · NA
Acupressure Wristbands for GLP-1RA Related Nausea
A NA study of Nausea, sponsored by Florencia Ziemke.
- Active
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT06939517: Active NA study of Nausea, sponsored by Florencia Ziemke.
NCT06939517 is a NA study of Nausea that is active but no longer recruiting, run by Florencia Ziemke. The registered enrollment target is 35 participants, below the 242-participant average among 17 other Nausea trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06939517, a NA study of Nausea, is active but no longer recruiting, sponsored by Florencia Ziemke.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
Nausea is a common side effect of GLP-1RA medications used for treatment of Type 2 diabetes mellitus and obesity. Current recommendations for nausea relief include the use of dietary changes and prescription anti-emetics. Acupressure wristbands Sea-Band are FDA cleared for nausea relief in other indications such as motion sickness, morning sickness in pregnancy, post-operative nausea, chemotherapy associated nausea. We hypothesized that acupressure wristbands could alleviate nausea in persons taking GLP-1RA.
Primary Outcome
Participants will be asked to apply the wristbands at the onset of nausea, and record each nausea episode using a tracker. Weekly touch points with the study team will review their number of nausea episodes, and if nausea relief was obtained.
Conditions Studied
Interventions
- DEVICE SeaBand
Study Locations (1)
Florida
- Evexia Medical - Jupiter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2025-04-13 |
| Phase | NA |
What the registry record for NCT06939517 still lists
NCT06939517 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 242-participant average among 17 other Nausea trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Nausea appearing as the primary indexed condition, and to 1 intervention - of which SeaBand is the first listed.
NCT06939517 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06939517 about?
NCT06939517 is a clinical study titled "Acupressure Wristbands for GLP-1RA Related Nausea". Nausea is a common side effect of GLP-1RA medications used for treatment of Type 2 diabetes mellitus and obesity. Current recommendations for nausea relief include the use of dietary changes and prescription anti-emetics. Acupressure wristbands Sea-Band are FDA cleared for nausea relief in other ind...
What is the current status of trial NCT06939517?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2024-02-01. Estimated completion is 2025-04-13.
What conditions does trial NCT06939517 study?
This clinical trial studies the following conditions: Nausea.
What interventions are being tested in trial NCT06939517?
The interventions under investigation include: SeaBand (DEVICE).
Who is sponsoring clinical trial NCT06939517?
This trial is sponsored by Florencia Ziemke, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06939517 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nausea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06939517's enrollment target sits among peer trials
35 17th of 17 higher than 1 of 17 other Nausea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nausea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting
RECRUITING · NA
-
Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
RECRUITING · NA
-
Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment
RECRUITING · NA
-
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
COMPLETED · NA
-
Virtual Reality at End-of-life
COMPLETED · NA
-
Inhaled Isopropyl Alcohol for Treatment of Nausea
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI